Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 81

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 81
---
 definitive agreement providing for a Superior Offer, subject to compliance with the procedural 
 terms and conditions set forth in the Merger Agreement and the payment of the Company Termination Fee of $43,425,000 (representing approximately 3.0% of STAAR’s implied equity value), which is reduced to $14,475,000 (representing approximately  
 1.0% of STAAR’s implied equity value) in the case of an acquirer who makes an Acquisition Proposal which, before the expiration of the 45-day window shop period, the Board determines constitutes or could                                          
 reasonably be expected to lead to a Superior Offer, as further discussed in the sections of this proxy statement titled “The Merger Agreement—Termination of the Merger Agreement” and “The Merger                                                   
 Agreement—Termination Fees”;                                                                                                                                                                                                                         |

-49-

| • |     | the fact that the Company Termination Fee was viewed by the Board as relatively favorable to the Company under           
 the circumstances and not likely to preclude or unduly deter another party from making a competing acquisition proposal; |

| • |     | the Board’s right, under the Merger Agreement, to withdraw, qualify or modify its recommendation that STAAR                
 stockholders vote to adopt the Merger Agreement under certain circumstances, subject to the terms of the Merger Agreement; |

| • |     | the fact that the Merger is not subject to a financing condition, and that Alcon has represented that it has and 
 will have available funds sufficient to pay the Merger Consideration;                                            |

| • |     | Alcon’s obligations under the Merger Agreement to use reasonable best efforts to take all actions necessary                                                                                                                                              
 to consummate the Merger and the other transactions contemplated by the Merger Agreement as promptly as practicable, including obtaining third-party approvals necessary to consummate the Merger, and Alcon’s obligation to take all actions            
 necessary, proper or advisable to eliminate any impediment under antitrust or foreign investment laws and obtain certain required regulatory approvals, subject to certain limitations set forth in the Merger Agreement (as discussed in the section of 
 this proxy statement titled “The Merger Agreement—Efforts to Close the Merger”);                                                                                                                                                                         |

| • |     | the Alcon Termination Fee of $72,375,000 (representing approximately 5% of STAAR’s implied equity value)                                                                                                                              
 payable to STAAR if the Merger Agreement is terminated in certain circumstances relating to a failure to timely